Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amniotic fluid and placental stem cells.

Dawn M Delo1, Paolo De Coppi, Georg Bartsch

  • 1Wake Forest University School of Medicine, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.

Methods in Enzymology
|December 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.

Drug discovery today·2016
Same author

A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.

Journal of biomedical materials research. Part B, Applied biomaterials·2016
Same author

Re: A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma.

The Journal of urology·2016
Same author

Re: Endogenous Formaldehyde is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.

The Journal of urology·2016
Same author

Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase.

The Journal of urology·2016
Same author

Re: Sex Hormone-Dependent tRNA Halves Enhance Cell Proliferation in Breast and Prostate Cancers.

The Journal of urology·2016

Amniotic fluid and placenta contain stem cells with therapeutic potential. These progenitor cells can differentiate into multiple tissue types, offering future treatments for congenital and adult disorders.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Human amniotic fluid has been utilized for prenatal diagnosis for over 70 years.
  • It serves as a safe and reliable screening tool for developmental and genetic diseases.

Purpose of the Study:

  • To explore the therapeutic potential of cells from amniotic fluid and placenta beyond diagnostic applications.
  • To investigate the isolation and characterization of pluripotent progenitor cells for future therapies.

Main Methods:

  • Isolation and characterization of progenitor cells from human amniotic fluid and placenta.
  • Experiments detailing the differentiation capabilities of these cells into multiple tissue types.

Main Results:

  • A subset of cells from amniotic fluid and placenta exhibits prolonged undifferentiated proliferation.

Related Experiment Videos

  • These cells demonstrate the ability to differentiate into cell types from all three germ layers.

    • Conclusions:

    • Amniotic fluid and placental stem cells hold significant promise for novel regenerative therapies.
    • Future applications may include treating newborns with congenital malformations and adults using cryopreserved cells.